Metastatic Melanoma

Showing NaN - NaN of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Melanoma Trial in New York (Lifileucel (LN-144))

Recruiting
  • Metastatic Melanoma
  • Lifileucel (LN-144)
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Jan 23, 2023

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Phoenix, Arizona
  • +48 more
Jan 3, 2023

Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, NSCLC Trial in Worldwide (Lifileucel, LN-145, Pembrolizumab)

Recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel
  • +5 more
  • La Jolla, California
  • +44 more
Dec 16, 2022

Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

Recruiting
  • Unresectable Melanoma
  • +3 more
  • IOV-4001
  • Louisville, Kentucky
  • +2 more
Nov 21, 2022

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Metastatic Melanoma, Skin Cancer, Tumor Trial in New York (ADI PEG 20)

Completed
  • Metastatic Melanoma
  • +2 more
  • ADI PEG 20
  • New York, New York
  • +1 more
Oct 3, 2022

AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

Recruiting
  • AIDS-Related Non-Hodgkin Lymphoma
  • +29 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Birmingham, Alabama
  • +12 more
Aug 4, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in Orlando, Louisville, New York (Lifileucel)

Available
  • Unresectable Melanoma
  • Metastatic Melanoma
  • Lifileucel
  • Orlando, Florida
  • +2 more
Jul 19, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Metastatic Melanoma Trial in United States (Placebo for antibiotic, Vancomycin pretreatment, Nivolumab)

Completed
  • Metastatic Melanoma
  • Placebo for antibiotic
  • +4 more
  • Los Angeles, California
  • +6 more
Jun 7, 2022

Metastatic Melanoma Trial in United States (IN10018, Cobimetinib)

Recruiting
  • Metastatic Melanoma
  • Miami, Florida
  • +4 more
Mar 29, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in France, United States (Nivolumab, Ipilimumab, Placebo)

Completed
  • Unresectable Melanoma
  • Metastatic Melanoma
  • San Francisco, California
  • +20 more
Feb 16, 2022

Metastatic Melanoma Trial in United States (ipilimumab, nivolumab)

Active, not recruiting
  • Metastatic Melanoma
  • Hartford, Connecticut
  • +11 more
Mar 10, 2022

Metastatic Castration-resistant Prostrate Cancer, Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (BMS-936558

Completed
  • Metastatic Castration-resistant Prostrate Cancer
  • +3 more
  • BMS-936558 (MDX-1106)
  • Scottsdale, Arizona
  • +12 more
Dec 1, 2021

Metastatic Melanoma Trial in Worldwide (MORAb-004 (mAb))

Completed
  • Metastatic Melanoma
  • MORAb-004 (monoclonal antibody)
  • Scottsdale, Arizona
  • +28 more
Aug 6, 2021

Metastatic Melanoma Trial in Canada, United States (TH-302)

Terminated
  • Metastatic Melanoma
  • Los Angeles, California
  • +6 more
Mar 24, 2021

Metastatic Melanoma Trial in Worldwide (Lifileucel)

Active, not recruiting
  • Metastatic Melanoma
  • Lifileucel
  • La Jolla, California
  • +56 more
Mar 24, 2021

Metastatic Melanoma Trial in United States (vemurafenib + HD IL-2)

Terminated
  • Metastatic Melanoma
  • vemurafenib + HD IL-2
  • Tucson, Arizona
  • +20 more
Jan 28, 2021

Long-Term Quality of Life in Metastatic Melanoma Treated With

Completed
  • Metastatic Melanoma
  • EuroQoL EQ-5D-3L
  • +5 more
  • Basking Ridge, New Jersey
  • +5 more
Dec 15, 2020

Metastatic Melanoma Trial in United States (High Dose Interleukin-2, Ipilimumab)

Terminated
  • Metastatic Melanoma
  • Tucson, Arizona
  • +11 more
Dec 1, 2020

Melanoma, Metastatic Melanoma, Solid Tumor Trial in United Kingdom, United States (MLN2480)

Completed
  • Melanoma
  • +3 more
  • San Francisco, California
  • +15 more
Jul 28, 2020

Advanced Melanoma, Metastatic Melanoma Trial in Netherlands, Spain, United States (Nivolumab, Ipilimumab)

Completed
  • Advanced Melanoma
  • Metastatic Melanoma
  • Los Angeles, California
  • +13 more
Nov 14, 2019

Treatment Patterns and Clinical Response in Malignancy

Completed
  • Metastatic Renal Cell Carcinoma
  • Metastatic Melanoma
    • Tucson, Arizona
    • +44 more
    Jun 11, 2019